Therefore, COL1A1 may be the attractive target in the treatment of carcinoma, which participated in the metastasis and was a reliable biomarker and putative therapeutic target in many cancers (Liu et al., 2018; Ma, Chang & Bamodu, 2019; Oleksiewicz et al., 2017). This evidence concerns the gene COL1A1 and carcinoma.